TCBK:NASDAQTriCo Bancshares Analysis
Data as of 2026-05-04 - not real-time
$50.31
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
TriCo Bancshares is trading at $50.31, comfortably above the identified support level of $48.34 and below the resistance of $51.43, giving the price some cushion. The 20‑day SMA (≈$50.13) sits above the 50‑day SMA (≈$48.66), reinforcing a short‑term bullish alignment, while the 200‑day SMA (≈$46.69) remains well below the current price, confirming a longer‑term uptrend. Momentum indicators are mixed: the RSI hovers around the mid‑50s, suggesting no immediate overbought pressure, but the MACD histogram has turned slightly negative, hinting at a potential short‑term pullback. Volume has been on a decreasing trend, which may limit the strength of any breakout. Fundamentally, the stock trades at a forward PE of ~11.6 versus an industry average of ~17.5, indicating a clear valuation discount. Revenue grew almost 10% year‑over‑year and earnings per share beat expectations, supporting the upside narrative. A dividend yield of 2.79% with a payout ratio under 36% points to a sustainable income component. Analyst consensus is “Buy” with a mean target of $56, implying roughly 11% upside from the current level.
The combination of a modest beta, low volatility relative to peers, and a solid balance sheet (cash far exceeds debt) keeps overall risk modest. However, the decreasing volume and a marginally bearish MACD signal caution investors to monitor near‑term price action. Given the valuation discount, earnings momentum, and dependable dividend, the stock is positioned favorably for medium‑ to long‑term investors, while short‑term traders may prefer a cautious hold until clearer volume support emerges.
The combination of a modest beta, low volatility relative to peers, and a solid balance sheet (cash far exceeds debt) keeps overall risk modest. However, the decreasing volume and a marginally bearish MACD signal caution investors to monitor near‑term price action. Given the valuation discount, earnings momentum, and dependable dividend, the stock is positioned favorably for medium‑ to long‑term investors, while short‑term traders may prefer a cautious hold until clearer volume support emerges.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support with limited upside
- Bearish MACD histogram suggesting short‑term weakness
- Decreasing volume reducing conviction in immediate moves
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued relative to industry PE multiple
- Strong earnings growth and positive EPS surprise
- Sustainable dividend yielding near 3%
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Consistent revenue and earnings expansion
- Robust balance sheet with cash covering debt comfortably
- Favorable macro environment for regional banks and steady dividend
Key Metrics & Analysis
Financial Health
Revenue Growth10.70%
Profit Margin30.99%
P/E Ratio12.8
ROE9.99%
ROA1.30%
P/B Ratio1.2
Industry P/E17.5
Technical Analysis
TrendBullish
RSI54.6
Support$48.34
Resistance$51.43
MA 20$50.13
MA 50$48.66
MA 200$46.69
MACDBearish
VolumeDecreasing
Fear & Greed Index88.54
Valuation
Target Price$56.00
Upside/Downside11.31%
GradeUndervalued
TypeBlend
Dividend Yield2.79%
Risk Assessment
Beta0.93
Volatility21.59%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.